Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

It is now well established that regulatory T (T(R)) cells can inhibit harmful immunopathological responses directed against self or foreign antigens. However, many key aspects of T(R) cell biology remain unresolved, especially with regard to their antigen specificities and the cellular and molecular pathways involved in their development and mechanisms of action. We will review here recent findings in these areas, outline a model for how T(R) cells may inhibit the development of immune pathology and discuss potential therapeutic benefits that may arise from the manipulation of T(R) cell function.

Original publication




Journal article


Nat immunol

Publication Date





816 - 822


Abatacept, Animals, Antigens, CD, Antigens, Differentiation, Autoimmune Diseases, CTLA-4 Antigen, Cell Adhesion, Cytokines, Humans, Immunoconjugates, Mice, Models, Immunological, Receptors, Interleukin-2, Self Tolerance, T-Lymphocyte Subsets, T-Lymphocytes, Regulatory, Thymus Gland